Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 20,000 shares at $50.40 ($1.0M) on 2023-01-17, disclosed to the SEC on 2023-01-18.
Open-market sale of $1.0M HALO by SVP, CHIEF TECHNICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.40 | 8,878 | $447K | 44.3% |
| 2 | $50.40 | 8,878 | $447K | 44.3% |
| 3 | $50.93 | 1,122 | $57K | 5.7% |
| 4 | $50.93 | 1,122 | $57K | 5.7% |
| Total | $50.46 avg | 20,000 | $1.0M | 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |